JP2022540353A5 - - Google Patents

Info

Publication number
JP2022540353A5
JP2022540353A5 JP2021577587A JP2021577587A JP2022540353A5 JP 2022540353 A5 JP2022540353 A5 JP 2022540353A5 JP 2021577587 A JP2021577587 A JP 2021577587A JP 2021577587 A JP2021577587 A JP 2021577587A JP 2022540353 A5 JP2022540353 A5 JP 2022540353A5
Authority
JP
Japan
Prior art keywords
compound according
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021577587A
Other languages
English (en)
Japanese (ja)
Other versions
JP7560136B2 (ja
JP2022540353A (ja
Filing date
Publication date
Priority claimed from CN201910572091.9A external-priority patent/CN112142743A/zh
Application filed filed Critical
Publication of JP2022540353A publication Critical patent/JP2022540353A/ja
Publication of JP2022540353A5 publication Critical patent/JP2022540353A5/ja
Application granted granted Critical
Publication of JP7560136B2 publication Critical patent/JP7560136B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021577587A 2019-06-28 2020-06-24 チロシンキナーゼ2活性を仲介する複素環式化合物 Active JP7560136B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201910572091.9 2019-06-28
CN201910572091.9A CN112142743A (zh) 2019-06-28 2019-06-28 杂环类化合物、其制备方法及其在医药学上的应用
PCT/CN2020/098105 WO2020259584A1 (en) 2019-06-28 2020-06-24 Heterocyclic compounds for mediating tyrosine kinase 2 activity

Publications (3)

Publication Number Publication Date
JP2022540353A JP2022540353A (ja) 2022-09-15
JP2022540353A5 true JP2022540353A5 (enExample) 2023-06-02
JP7560136B2 JP7560136B2 (ja) 2024-10-02

Family

ID=73869063

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021577587A Active JP7560136B2 (ja) 2019-06-28 2020-06-24 チロシンキナーゼ2活性を仲介する複素環式化合物

Country Status (12)

Country Link
US (2) US12448382B2 (enExample)
EP (1) EP3990449A4 (enExample)
JP (1) JP7560136B2 (enExample)
KR (1) KR102926602B1 (enExample)
CN (2) CN112142743A (enExample)
AU (1) AU2020301437B2 (enExample)
BR (1) BR112021026531A2 (enExample)
CA (1) CA3144799A1 (enExample)
MX (1) MX2021015969A (enExample)
PH (1) PH12021553257A1 (enExample)
TW (1) TWI851747B (enExample)
WO (1) WO2020259584A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112142743A (zh) 2019-06-28 2020-12-29 广州诺诚健华医药科技有限公司 杂环类化合物、其制备方法及其在医药学上的应用
TWI782599B (zh) * 2020-07-02 2022-11-01 美商輝瑞股份有限公司 胺基嘧啶基衍生物
CN113234081A (zh) * 2021-05-27 2021-08-10 东南大学 一种吡咯并吡唑衍生物与dmpeda做脲的制备方法
EP4423086A1 (en) 2021-10-25 2024-09-04 Kymera Therapeutics, Inc. Tyk2 degraders and uses thereof
WO2025124465A1 (en) * 2023-12-15 2025-06-19 Beijing Innocare Pharma Tech Co., Ltd. Method for treating atopic dermatitis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014500254A (ja) * 2010-11-09 2014-01-09 セルゾーム リミティッド Tyk2阻害剤としてのピリジン化合物およびそのアザ類似体
WO2012145581A1 (en) * 2011-04-20 2012-10-26 Janssen Pharmaceutica Nv Disubstituted octahy-dropyrrolo [3,4-c] pyrroles as orexin receptor modulators
WO2013146963A1 (ja) * 2012-03-28 2013-10-03 武田薬品工業株式会社 複素環化合物
CN105622638B (zh) * 2014-10-29 2018-10-02 广州必贝特医药技术有限公司 嘧啶或吡啶并吡啶酮类化合物及其制备方法和应用
ES2854703T3 (es) * 2015-07-09 2021-09-22 Merck Patent Gmbh Compuestos de heteroarilo como inhibidores de BTK y usos de los mismos
EP3684361A4 (en) * 2017-09-20 2021-09-08 Kura Oncology, Inc. SUBSTITUTED INHIBITORS OF MENIN-MLL AND METHOD OF USING
CN112142743A (zh) * 2019-06-28 2020-12-29 广州诺诚健华医药科技有限公司 杂环类化合物、其制备方法及其在医药学上的应用

Similar Documents

Publication Publication Date Title
JP2022540353A5 (enExample)
JP2022538215A5 (enExample)
JP2019194236A5 (enExample)
JP2011508438A5 (enExample)
JP2007518723A5 (enExample)
JP2010501534A5 (enExample)
JP2008526765A5 (enExample)
JP2012522259A5 (enExample)
JP2018184433A5 (enExample)
JP2013500200A5 (enExample)
JP2023508938A5 (enExample)
JP2008266364A5 (enExample)
JP2020528637A5 (enExample)
JP2006506499A5 (enExample)
JP2022124475A5 (enExample)
JPWO2021220648A5 (enExample)
JP2020504434A5 (enExample)
JP2022546539A5 (enExample)
JP2020054657A5 (enExample)
JP2021514452A5 (enExample)
JP2019094054A5 (enExample)
JP2022507958A5 (enExample)
JP2009501689A5 (enExample)
JP2009532412A5 (enExample)
JP2023503428A5 (enExample)